Treatment and prevention of remote ischemia-reperfusion injury

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10286047
APP PUB NO 20160008442A1
SERIAL NO

14773020

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a contact activation system inhibitor, preferably a C1INH, for use in the treatment and/or prevention of remote ischemia-reperfusion injury (IRI), comprising administering the contact activation system inhibitory to an individual.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CSL BEHRING GMBH35041 MARBURG
UNIVERSITAET BERNBERN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Duehrkop-Sisewitsch, Claudia Knivsta, SE 2 14
Miescher, Sylvia Bern, CH 13 64
Nolte, Marc Marburg, DE 54 197
Rieben, Robert Hinterkappelen, CH 3 14
Spirig, Rolf Bern, CH 7 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 14, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 14, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00